P-tau217 was picked as a non-specific antigen for specificity and selectivity experiments since it is a particularly promising indicator of AD and is found in blood with amyloid beta biomarkers, consistently demonstrating greater efficiency compared to other p-tau isoforms [27]. Here, MAPT is linked to Alzheimer disease.